BPH treatment options when drugs are not enough
Can I wear contacts after age 50?
Eye care in an emergency
Harvard study: Six healthy diets linked with better long-term brain health
Study: Taking GLP-1 drugs may increase risk of key nutrient deficiencies
Another way to manage GERD
What is the "gout diet"?
HPV testing at home: A new option for women
How can I tell if I'm developing arthritis or musculoskeletal syndrome of menopause?
How to increase appetite
Diseases & Conditions Archive
Articles
A new approach to peripheral artery disease
A 2025 randomized controlled trial found that GLP-1 receptor agonists, the blockbuster drugs approved to treat diabetes and obesity, boosted the walking ability of people with diabetes and peripheral artery disease (PAD) in the legs. The news is encouraging, since there are few effective treatments for PAD-reduced blood flow in the limbs that leads to pain with activity. However, it will take more evidence before doctors feel comfortable prescribing GLP-1s if a person only has PAD.
Diabetes and obesity drug shows promise for fatty liver disease
Semaglutide, a GLP-1 agonist used to treat diabetes and obesity, may also help people with metabolic dysfunction-associated steatohepatitis, a severe stage of fatty liver disease, suggests a 2025 study.
BPH treatment options when drugs are not enough
Can I wear contacts after age 50?
Eye care in an emergency
Harvard study: Six healthy diets linked with better long-term brain health
Study: Taking GLP-1 drugs may increase risk of key nutrient deficiencies
Another way to manage GERD
What is the "gout diet"?
HPV testing at home: A new option for women
How can I tell if I'm developing arthritis or musculoskeletal syndrome of menopause?
How to increase appetite
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up
